|Bid||3.8500 x 3200|
|Ask||3.8700 x 1300|
|Day's Range||3.5800 - 4.0800|
|52 Week Range||1.4000 - 6.0700|
|Beta (5Y Monthly)||0.52|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 05, 2020 - Nov. 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.00|
WILMINGTON, Del., July 29, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ GS: AMRS) common stock (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Amyris and its Board of Directors (the “Board”), is captioned Sabatini v. Amyris, Inc., Case No. 1:20-cv-01013 (D. Del.). If you wish to discuss this action or have any questions regarding this notice or your rights, please contact plaintiff’s counsel, Seth D. Rigrodsky or Gina M. Serra, toll free at (888) 969-4242, by e-mail at firstname.lastname@example.org, or at https://www.rigrodskylong.com/offices-contact.On July 6, 2020, Amyris filed a proxy statement (the “Proxy Statement”) with the United States Securities and Exchange Commission. The Proxy Statement scheduled a special meeting of Amyris’ stockholders to vote upon the approval of: (i) the issuance of shares of Amyris’ common stock issuable upon exercise by Foris Ventures, LLC of its option to convert all or any portion of the secured indebtedness outstanding under the Amended and Restated Loan and Security Agreement dated October 28, 2019, as further amended on June 1, 2020, into shares of the Company’s common stock; and (ii) the issuance of shares of Amyris common stock issuable upon the conversion of the Company’s Series E Convertible Preferred Stock. Among other things, the Complaint alleges that defendants issued materially incomplete disclosures in the Proxy Statement. If you wish to serve as lead plaintiff, you must move the Court no later than September 28, 2020. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.Attorney advertising. Prior results do not guarantee a similar outcome.CONTACT:Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (Toll Free) (302) 295-5310 Fax: (302) 654-7530 email@example.com https://rl-legal.com
Shares of Amyris (NASDAQ: AMRS) gained over 12% today after the company announced it had signed a binding term sheet with the Infectious Disease Research Institute (IDRI) to collaborate on a SARS-CoV-2 vaccine candidate. Specifically, IDRI will develop a vaccine candidate based on its RNA vaccine platform, while Amyris will supply squalene for use in the vaccine adjuvant.
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Amyris, Inc.